Suicide prevention program for sexual and gender minority youth
Suicide Prevention for Sexual and Gender Minority Youth (Randomized Controlled Trial)
This study is testing a new suicide prevention program for LGBTQ+ youth and young adults to see if it can help reduce their risk of trying to harm themselves.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 170 (estimated) |
| Ages | 15 Years to 29 Years |
| Sex | All |
| Sponsor | San Diego State University Academic / other |
| Locations | 1 site (San Diego, California) |
| Trial ID | NCT05669976 on ClinicalTrials.gov |
What this trial studies
This study evaluates a newly-developed suicide prevention program specifically designed for sexual and gender minority youth and emerging adults. It involves a randomized controlled trial to assess the program's effectiveness in reducing the risk of suicide attempts among participants. The intervention includes a Safety Planning Intervention combined with Navigation Services to support at-risk individuals. The study aims to address the significant mental health disparities faced by this vulnerable population.
Who should consider this trial
Good fit: Ideal candidates for this study are individuals aged 15 to 29 who identify as part of the sexual and gender minority community and have reported suicidal ideation and a history of suicide attempts.
Not a fit: Patients who are currently experiencing an immediate intention to attempt suicide will not benefit from this study.
Why it matters
Potential benefit: If successful, this program could significantly reduce suicide attempts among sexual and gender minority youth, improving their mental health outcomes.
How similar studies have performed: While there have been various interventions targeting suicide prevention, this specific approach tailored for sexual and gender minority youth is relatively novel and has not been extensively tested.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: 1) age 15 to 29 years; 2) identifies as gay, lesbian, bisexual, transgender, genderqueer, asexual, pansexual, non-binary, or another non-exclusively heterosexual or cisgender identity, and/or reports same-gender romantic attraction, and/or reports same-gender sexual behavior in the past 12 months; 3) resides in Southern California; 4) speaks English; 5) is willing and able to provide informed consent; 6) reports suicidal ideation over the past two weeks, as indicated by the clinician-administered Columbia-Suicide Severity Rating Scale (C-SSRS) Baseline version; and 7) reports a lifetime history of one or more suicide attempts. Exclusion Criteria: 1) Individuals with immediate intention to attempt suicide will be excluded.
Where this trial is running
San Diego, California
- San Diego State University — San Diego, California, United States (Recruiting)
Study contacts
- Principal investigator: Aaron J Blashill, Ph.D. — San Diego State University
- Study coordinator: Aaron J Blashill, Ph.D.
- Email: ajblashill@sdsu.edu
- Phone: 619-594-2245
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.